Previous studies are limited to the identification of possible target genes by evaluating changes in gene expression by increasing or decreasing BORIS levels;5,6,11,19,34 however, our de novo pathway enrichment analysis allowed us to perform a novel selection (based on hundreds of experimental data available in public databases) of potential genes relevant in cancer, which are closely related through AR and BORIS. The gene discussed is CTCFL; the disease is cancer.